Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,840 | 101 | 93.9% |
| Education | $120.31 | 15 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $425.70 | 31 | $0 (2023) |
| Fresenius USA Marketing, Inc. | $305.73 | 14 | $0 (2024) |
| Amgen Inc. | $185.45 | 11 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $179.64 | 7 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $178.31 | 4 | $0 (2024) |
| Travere Therapeutics, Inc. | $94.15 | 13 | $0 (2024) |
| Vifor Pharma, Inc. | $80.54 | 5 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $78.72 | 4 | $0 (2021) |
| OPKO Pharmaceuticals, LLC | $77.59 | 5 | $0 (2021) |
| Shire North American Group Inc | $46.60 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $340.87 | 20 | Novartis Pharmaceuticals Corporation ($159.71) |
| 2023 | $433.06 | 28 | Horizon Therapeutics plc ($252.30) |
| 2022 | $376.65 | 13 | Fresenius USA Marketing, Inc. ($143.42) |
| 2021 | $274.43 | 21 | Horizon Therapeutics plc ($113.75) |
| 2020 | $175.91 | 11 | Fresenius USA Marketing, Inc. ($69.00) |
| 2019 | $151.47 | 10 | Fresenius USA Marketing, Inc. ($33.91) |
| 2018 | $60.13 | 4 | Keryx Biopharmaceuticals, Inc. ($16.21) |
| 2017 | $147.77 | 9 | Amgen Inc. ($47.45) |
All Payment Transactions
116 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Immunology | ||||||
| 11/25/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $38.15 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: Immunology | ||||||
| 06/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 05/22/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $15.86 | General |
| 05/22/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/22/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 05/21/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.11 | General |
| 05/14/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 05/14/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 05/14/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 04/30/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.38 | General |
| 02/29/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.38 | General |
| 02/27/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Phosphate binder for ESRD | ||||||
| 02/21/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 02/08/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/29/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: KRYSTEXXA | ||||||
| 12/15/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: KRYSTEXXA | ||||||
| 12/07/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Inflammation | ||||||
| 12/06/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 11/15/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Education | Cash or cash equivalent | $13.60 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 576 | 1,493 | $374,820 | $145,977 |
| 2022 | 12 | 547 | 1,292 | $354,501 | $149,788 |
| 2021 | 8 | 467 | 1,009 | $227,181 | $87,415 |
| 2020 | 9 | 481 | 1,099 | $248,232 | $89,693 |
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 66 | 132 | $72,996 | $35,165 | 48.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 102 | 256 | $52,224 | $23,197 | 44.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 60 | 100 | $46,500 | $21,958 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 178 | $36,668 | $14,788 | 40.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 30 | 72 | $38,376 | $11,766 | 30.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 89 | $35,333 | $11,753 | 33.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 65 | 192 | $27,456 | $10,450 | 38.1% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 28 | 204 | $26,112 | $6,796 | 26.0% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 28 | 202 | $25,856 | $6,480 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,372 | $1,899 | 35.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 17 | 26 | $2,652 | $1,002 | 37.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 24 | 25 | $5,275 | $722.74 | 13.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 89 | 223 | $123,319 | $60,866 | 49.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 53 | 79 | $36,735 | $17,853 | 48.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 75 | 222 | $45,288 | $17,259 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 167 | $34,301 | $14,328 | 41.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 72 | $28,584 | $10,845 | 37.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 50 | 147 | $21,021 | $8,168 | 38.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 16 | 39 | $20,787 | $6,488 | 31.2% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 25 | 125 | $16,000 | $4,764 | 29.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 25 | 125 | $16,000 | $4,545 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $6,952 | $2,668 | 38.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 30 | 44 | $4,488 | $1,659 | 37.0% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 27 | 27 | $1,026 | $344.22 | 33.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 127 | 326 | $66,504 | $25,684 | 38.6% |
About Dr. Muhammad Bashir, MD
Dr. Muhammad Bashir, MD is a Internal Medicine healthcare provider based in Athens, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1114230430.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Bashir, MD has received a total of $1,960 in payments from pharmaceutical and medical device companies, with $340.87 received in 2024. These payments were reported across 116 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,840).
As a Medicare-enrolled provider, Bashir has provided services to 2,071 Medicare beneficiaries, totaling 4,893 services with total Medicare billing of $472,874. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Athens, GA
- Active Since 07/15/2010
- Last Updated 07/30/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1114230430
Products in Payments
- KRYSTEXXA (Biological) $445.65
- Velphoro (Drug) $305.73
- Auryxia (Drug) $188.53
- Veltassa (Drug) $123.11
- Fabhalta (Drug) $90.84
- Parsabiv (Biological) $66.62
- JYNARQUE (Drug) $63.72
- Parsabiv (Drug) $47.90
- Rayaldee (Drug) $41.63
- FARXIGA (Drug) $37.22
- RAYALDEE (Drug) $35.96
- ACTHAR (Biological) $33.46
- NATPARA (PARATHYROID HORMONE) (Drug) $32.91
- Sensipar (Drug) $30.30
- Vafseo (Drug) $24.61
- TAVNEOS (Drug) $20.68
- ENTRESTO (Drug) $19.93
- Kerendia (Drug) $17.88
- ULTOMIRIS (Biological) $17.62
- FERAHEME (Drug) $17.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Athens
Dr. Catherine Marti, Md, MD
Internal Medicine — Payments: $295,383
Kent Nilsson, M.d, M.D
Internal Medicine — Payments: $175,364
Petros Nikolinakos, M.d, M.D
Internal Medicine — Payments: $151,381
Karan Julka, Md, MD
Internal Medicine — Payments: $69,118
Antonio Sotolongo, M.d, M.D
Internal Medicine — Payments: $47,039
Asif Qadri, M.d, M.D
Internal Medicine — Payments: $46,806